EIKN Eikon Therapeutics, Inc.
Nasdaq · SEC CIK 1861123 · EDGAR
- Bought, last 12 months
- $52.15M 6 purchases by 6 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 14 since 2026-02-06, latest 2026-09-08 16:33
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Column Group Opportunity III, LP | 10% | $38.12M | — |
| Wolfe Josh | Dir, 10% | $5.00M | — |
| Lux Ventures V, L.P. | 10% | $5.00M | — |
| FRAZIER KENNETH C | Dir | $2.00M | — |
| Column Group IV GP, LP | 10% | $1.03M | — |
| Foresite Capital Opportunity Management V, LLC | 10% | $1000.0K | — |
| PERLMUTTER ROGER M | See remarks, Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-08 16:33 | 2026-09-03 | EIKN | Column Group IV GP, LP | 10% | P - Purchase | $11.56 | +89.2K | 89.2K | New | +$1.03M |
| DI | 2026-02-10 | 2026-02-06 | EIKN | PERLMUTTER ROGER M | See remarks, Dir | C - Cnv Deriv | — | +284.9K | 284.9K | New | — |
| DMI | 2026-02-09 | 2026-02-06 | EIKN | Column Group Opportunity III, LP | 10% | P - Purchase | $18.00 | +2.12M | 4.31M | +97% | +$38.12M |
| DMI | 2026-02-09 | 2026-02-06 | EIKN | Column Group Opportunity III, LP | 10% | C - Cnv Deriv | — | +3.60M | 95.5K | New | — |
| DMI | 2026-02-06 | 2026-02-04 | EIKN | Lux Ventures V, L.P. | 10% | P - Purchase | $18.00 | +277.8K | 138.9K | New | +$5.00M |
| DMI | 2026-02-06 | 2026-02-06 | EIKN | Lux Ventures V, L.P. | 10% | C - Cnv Deriv | — | +5.70M | 2.39M | New | — |
| DMI | 2026-02-06 | 2026-02-04 | EIKN | Wolfe Josh | Dir, 10% | P - Purchase | $18.00 | +277.8K | 138.9K | New | +$5.00M |
| DMI | 2026-02-06 | 2026-02-06 | EIKN | Wolfe Josh | Dir, 10% | C - Cnv Deriv | — | +5.70M | 2.39M | New | — |
| DMI | 2026-02-06 | 2026-02-04 | EIKN | Foresite Capital Opportunity Management V, LLC | 10% | C - Cnv Deriv | $0.00 | +4.04M | 1.68M | New | $0 |
| DI | 2026-02-06 | 2026-02-04 | EIKN | Foresite Capital Opportunity Management V, LLC | 10% | P - Purchase | $18.00 | +55.6K | 1.32M | +4% | +$1000.0K |
| 2026-02-06 | 2026-02-04 | EIKN | FRAZIER KENNETH C | Dir | P - Purchase | $18.00 | +111.1K | 111.1K | New | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations